Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Plos One|July 8, 2017
Coronary artery disease-associated genetic variants and biomarkers of inflammationMorten Krogh Christiansen, Sanne Bøjet Larsen, Mette Nyegaard, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 19, 2024
A core outcome set for trials evaluating self-management interventions in people with severe mental illness and coexisting type 2 diabetesClaire Carswell, Jo Taylor, Richard I G Holt, et al.
Diabetes Care|November 5, 2013
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetesMaike Anderssohn, Stela McLachlan, Nicole Lüneburg, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2022
Purification and Analysis of Circulating Lipid ParticlesBarnaby W R Roper, Basmah Al-Sayejh, Ahmed Al-Aufi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2024
Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excessLina Schiffer, Imken Oestlund, Jacky L Snoep, et al.
Diabetes & Vascular Disease Research|January 19, 2012
Complement C3 is a novel plasma clot component with anti-fibrinolytic propertiesJoanna-Marie Howes, Victoria R Richardson, Kerrie A Smith, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 9, 2024
Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Endocrinology|July 18, 2009
Vascular insulin-like growth factor-I resistance and diet-induced obesityHelen Imrie, Afroze Abbas, Hema Viswambharan, et al.
The Lancet. Diabetes & Endocrinology|February 29, 2020
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trialIda Pernicova, Stephen Kelly, Sharon Ajodha, et al.
Endocrine Connections|May 30, 2023
Evaluation of cardiovascular risk factors in long-term survivors of adult- and childhood-onset brain tumours: a pilot studyNikolaos Kyriakakis, Marilena Giannoudi, Satish S Kumar, et al.
Pageof 6